BioLamina

Sundbyberg, Sweden

BioLamina is a biotechnology company with a global presence, offering cell culture matrices for primary cells.

$18.3M raised

Sep 2023

Venture - Series Unknown

Top Investors

Lauxera Capital PartnersNorthisletBure Equity AB

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has BioLamina raised?

BioLamina has raised $18.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2023.

Who are BioLamina's investors?

BioLamina's investors include Lauxera Capital Partners, Northislet, Bure Equity AB.

Where is BioLamina headquartered?

BioLamina is headquartered in Sundbyberg, Sweden.

What does BioLamina do?

BioLamina is a biotechnology company with a global presence, offering cell culture matrices for primary cells.

What stage is BioLamina at?

BioLamina is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 12, 2023.

MLA

"BioLamina — Funding & Investors." VCBacked, September 12, 2023, https://www.vcbacked.co/company/biolamina. Accessed June 3, 2026.

APA

VCBacked. (2023). BioLamina — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/biolamina

Wikipedia (cite web)

{{cite web |title=BioLamina — Funding & Investors |url=https://www.vcbacked.co/company/biolamina |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 12, 2023.